Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
12.63
+1.58 (14.30%)
At close: Jan 14, 2026, 4:00 PM EST
12.05
-0.58 (-4.59%)
Pre-market: Jan 15, 2026, 8:00 AM EST
Crescent Biopharma Market Cap
Crescent Biopharma has a market cap or net worth of $246.91 million as of January 15, 2026.
Market Cap
246.91M
Enterprise Value
249.63M
1-Year Change
n/a
Ranking
Category
Stock Price
$12.63
Market Cap Chart
Since June 16, 2025, Crescent Biopharma's market cap has decreased from $308.79M to $246.91M, a decrease of -20.04%. That is a compound annual growth rate of -31.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2026 | 246.91M | 6.49% |
| Dec 31, 2025 | 231.86M | -24.91% |
| Jun 16, 2025 | 308.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 961.00B |
| Johnson & Johnson | 526.55B |
| AbbVie | 392.16B |
| UnitedHealth Group | 303.42B |
| AstraZeneca | 299.25B |
| Novartis AG | 278.73B |
| Merck & Co. | 275.53B |
| Novo Nordisk | 262.20B |